Education
About Us
Working with TipRanks
Follow Us
Pharmacorp Rx Inc. (TSE:PCRX)
:PCRX
RESEARCH TOOLSreports
PCRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.40 - C$0.81
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.29K
Market Cap
C$54.16M
Enterprise ValueC$47.85M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Dec 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding110,533,680
10 Day Avg. Volume19,108
30 Day Avg. Volume30,292
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pharmacorp Rx Inc. News
PCRX FAQ
What was Pharmacorp Rx Inc.’s price range in the past 12 months?
Pharmacorp Rx Inc. lowest stock price was C$0.40 and its highest was C$0.81 in the past 12 months.
What is Pharmacorp Rx Inc.’s market cap?
Pharmacorp Rx Inc.’s market cap is C$54.16M.
When is Pharmacorp Rx Inc.’s upcoming earnings report date?
Pharmacorp Rx Inc.’s upcoming earnings report date is Dec 02, 2025 which is in 85 days.
How were Pharmacorp Rx Inc.’s earnings last quarter?
Pharmacorp Rx Inc. released its earnings results on Aug 15, 2025. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is Pharmacorp Rx Inc. overvalued?
According to Wall Street analysts Pharmacorp Rx Inc.’s price is currently Overvalued.
Does Pharmacorp Rx Inc. pay dividends?
Pharmacorp Rx Inc. does not currently pay dividends.
What is Pharmacorp Rx Inc.’s EPS estimate?
Pharmacorp Rx Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmacorp Rx Inc. have?
Pharmacorp Rx Inc. has 110,533,680 shares outstanding.
What happened to Pharmacorp Rx Inc.’s price movement after its last earnings report?
Pharmacorp Rx Inc. reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2%.
Which hedge fund is a major shareholder of Pharmacorp Rx Inc.?
Currently, no hedge funds are holding shares in TSE:PCRX
Company Description
Pharmacorp Rx Inc.
Proton Capital Corp is a Capital Pool Company. The principal business of the Company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.
Technical Analysis
Reliq Health Technologies
―
Neupath Health Inc.
―
KDA Group Inc.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―